ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1287

Utility of Vascular Findings By PET/CT Scan in the Diagnosis and Activity Assesment of Takayasu Arteritis

Bahtiyar Toz1, Zeynep Gözde Özkan2, Bahar Artim-Esen1, Burak Erer1, Sevil Kamali3, Ahmet Gul1, Lale Ocal3 and Murat Inanc4, 1Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Department of Nuclear Medicine,, Istanbul Faculty of Medicine, Istanbul, Turkey, Istanbul, Turkey, 3Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 4Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, İstanbul, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Takayasu arteritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Takayasu arteritis (TA) is a large-vessel vasculitis predominantly affecting the aorta and its main branches. Assessing disease activity is difficult and mainly based on the clinical findings, levels of acute phase reactants and angiography, but these items generally do not correlate well. The aim of the this study was to investigate the role of PET/CT in the diagnosis of the disease and assessing disease activity in TA

Methods: Thirty TA patients fulfilling ACR criteria underwent FDG-PET/CT were retrospectively assessed. Disease activity was defined according to NIH criteria. A nuclear physician who was blinded to clinical and laboratory data examined all PET/CT scans. PET/CT scans were considered negative if vascular FDG uptake relative to liver was grade 0 or 1 and positive if vascular uptake was grade 2 or 3 in at least one vessel area. The levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were measured concomitantly. The correlations between CRP and ESR with SUVmax values of vessels were investigated. CRP levels and ESRs were compared in subjects with or without positive PET/CT scans. Disease activity assessed by PET/CT was compared with the NIH criteria. ROC curve analyses were performed to assess the sensitivity and specificity of CRP and ESR according to PET/CT positivity.

Results: PET/CT was performed for diagnostic purposes early in the disease course in 9 subjects and to assess disease flare in 21 subjects on follow-up. The rate of a positive PET/CT examination tended to be higher in diagnostic/early use (88.9% positive) compared with use for flare-assessment (61.9% positive), although the difference was not significant (Fisher=0.2). Median CRP and ESR tended to be higher in PET/CT positive patients compared with PET/CT negative subjects (median CRP 19 vs. 14, p=0.16; mean ESR 59.8±36.5 vs. 35.2±19.7, p=0.07). ROC curve analysis showed an ESR of 38 mm/h or higher was 68.4% sensitivity and 66.7% specificity to predict a positive PET/CT examination (positive and negative predictive values 81.6% and 50%). A CRP of 14.5 mg/L or higher was 66.7% and 55.6% specific to predict a positive PET/CT examination (positive and negative predictive values 77.8% and 41.7%). While CRP was significantly correlated with mean SUVmax value of aorta (r=0.41, p=0.02), ESR was weakly correlated with SUVmax value of aorta (r=0.3, p=0.13). There was moderate agreement between PET-CT and NIH criteria (kappa 0.462, p=0.01, sensivity 81%, spesificity 67%)

Conclusion: These results suggested that clinical benefit of PET/CT may be higher in diagnostic use (early in the disease course) compared with use for flare assessment (after treatment) in TA. There was a moderate association between NIH activity criteria and PET/CT activity. The predictive value of increased ESR and CRP was similar for a positive PET/CT scan with lower negative predictive values. CRP levels had a better correlation with SUVmax levels of aorta compared to ESR. PET/CT is a promising tool in the diagnosis and activity assessment of TA but discrepancies with other activity parameters do exist.


Disclosure: B. Toz, None; Z. G. Özkan, None; B. Artim-Esen, None; B. Erer, None; S. Kamali, None; A. Gul, None; L. Ocal, None; M. Inanc, None.

To cite this abstract in AMA style:

Toz B, Özkan ZG, Artim-Esen B, Erer B, Kamali S, Gul A, Ocal L, Inanc M. Utility of Vascular Findings By PET/CT Scan in the Diagnosis and Activity Assesment of Takayasu Arteritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/utility-of-vascular-findings-by-petct-scan-in-the-diagnosis-and-activity-assesment-of-takayasu-arteritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/utility-of-vascular-findings-by-petct-scan-in-the-diagnosis-and-activity-assesment-of-takayasu-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology